India  

Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall

IndiaTimes Wednesday, 8 May 2024
UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to disclose that it had stopped manufacturing Covishield in Dec 2021 due to a fall in demand as well as the emergence of new variants. Covishield accounted for nearly 80% of Covid-19 vaccine doses administered in India.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions


Related videos from verified sources

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia [Video]

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia

After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed..

Credit: Oneindia     Duration: 03:03Published